Bobdinski Bobdinski PRO XHS, M, Long ,
XHS: XHS Monthly View - Primed for Liftoff
12 0 5
XHS, M Long
XHS Monthly View - Primed for Liftoff

A close above 60.51 will launch this into a monthly wave 3. Obviously be cautious with political risk in Washington on Trump Care - but these companies will undoubtedly get a nice push with a republican administration. Less regulation is a good thing for this basket. Would make an excellent 3-4 year IRA holding at this level imo.

dpasos dpasos ZBH, D, Long ,
ZBH: Long ZBH > 120.08
24 0 5
ZBH, D Long
Long ZBH > 120.08


dpasos dpasos EXEL, D, Long ,
EXEL: Long EXEL > $23.53
48 0 3
EXEL, D Long
Long EXEL > $23.53


dpasos dpasos DGX, D, Long ,
DGX: Long DGX > $98.83
40 0 0
DGX, D Long
Long DGX > $98.83


traderz26 traderz26 PRO REGN, 240, Short ,
REGN: REGN Should go down 5% or more
58 3 4
REGN, 240 Short
REGN Should go down 5% or more

REGN Should go down 5% or more

zhengster zhengster PRO BMY, 240,
BMY: BMY short term 10 days profit!
29 2 4
BMY, 240
BMY short term 10 days profit!

Similar upward pattern found in past. Health care is booming for last couple weeks, which confirms this is indeed a industry trend. BMY should reach at least up to $57 in 10 days but not sure what will happen after. Moving Average Convergence Divergence looks pretty solid. Buy now $55 and sell at $57 make $2 per share in 10 days.

matt.sulli42 matt.sulli42 TEVA, D, Short ,
TEVA: For my man vDr78-- a look at TEVA pharma
63 0 3
TEVA, D Short
For my man vDr78-- a look at TEVA pharma

Heres a stab at fibs for TEVA. unfortunately, i can't give you a target entry because it looks as if the company has been selling off all year, with the exception of a couple of pullbacks. Healthcare industry is risky atm! If I had to go in, it would be after a move upwards to the bottom rectangle. That's how I tend to chart at least. Be careful!

Cryptocol Cryptocol VDRM, 15,
VDRM: Possible double top @ 0.024
15 0 2
VDRM, 15
Possible double top @ 0.024

15/10/5 minute charts show double top @ 0.024. Going to hold this one but could be an indicator that we are going down.

iamajeya iamajeya IBB, D, Short ,
IBB: Biotech (IBB) - trade of the year
58 0 3
IBB, D Short
Biotech (IBB) - trade of the year

IBB is at multi-year cross roads. Ideal for straddles / strangles. A dropping RSI points to a weekly downtrend. Both trade ideas are plotted. From a fundamental perspective, I believe @realdonaldtrump is right, biotech is getting away with murder. I get one of my meds from overseas because it's 1/182 the cost. Yes, you read it right. It costs me $1 there ...

Cryptocol Cryptocol RNVA, 15, Long ,
RNVA: Long term potential (1-3 months)
196 0 2
RNVA, 15 Long
Long term potential (1-3 months)

Haven't posted on here in a bit but wanted to share my thoughts and most recent investment in $RNVA. I bought into RNVA on Tuesday at 0.083 per share for a little over 12k shares. I heard about the company through the penny stock subreddit and did some DD and decided to make an investment into it. My thoughts are as follows- Contrary to what Stocktwits ...

childreth43 childreth43 IBB, D, Short ,
IBB: Health Care down big after Trump press conference
37 0 4
IBB, D Short
Health Care down big after Trump press conference

Found support @ 55-EMA, but negative sentiment has us Bearish

KasperAndersen KasperAndersen PRO LABU, D, Long ,
LABU: LABU - decent RR
99 0 8
LABU, D Long
LABU - decent RR

RR = 6.25

wolfstreetswinger wolfstreetswinger ZLTQ, D, Long ,
ZLTQ: ZLTQ - Long - waiting for pullback
29 0 4
ZLTQ, D Long
ZLTQ - Long - waiting for pullback

Waiting for the pullback on this one

louisleetu louisleetu PRO AET, 240, Short ,
AET: Good Short Opportunity for Aetna
29 0 1
AET, 240 Short
Good Short Opportunity for Aetna

Strong sign showing a pullback soon.. Looks like this has been overbought..

Jgo Jgo NWBO, 60, Long ,
NWBO: $NWBO breakout thoughts ST movement that could carry
27 0 0
NWBO, 60 Long
$NWBO breakout thoughts ST movement that could carry

Analysis in chart. Didn't touch on Fib retracement but did est. SL @ .59 and .54 respectively Full Disclose NWBO @.48 Please follow my Twitter and Stocktwits account to stay current on my current bullish plays

MikeKonner MikeKonner MYGN, D, Long ,
MYGN: MYGN Earnings Oversold Play
16 0 0
MYGN, D Long
MYGN Earnings Oversold Play

MYGN took a beating after it's guidance underwhelm last quarter. I do believe that the reaction was overdone. MYGN has healthy revenue streams and growing drug and generics demand. TA confirms a re-entering into trading range of: PT 1: $25.00 for a ~20%+ return. PT 2: $30.00 for a 50% return.

AleksandrLombrozo AleksandrLombrozo AST, D, Long ,
AST: Asterias Biotherapeutics, Inc. triangle breakout
14 0 1
AST, D Long
Asterias Biotherapeutics, Inc. triangle breakout

Yesterday AST closed its session gapping up and breaking an upward triangle which might become a strong bullish opportunity. Although general downward motion is still intact, double bottom which was formed at the beginning of July and triangle breakout have every chance to finish with bearish mood. We would project the price to go up and reach at least $3.60 where ...

AleksandrLombrozo AleksandrLombrozo OVAS, W, Long ,
OVAS: OvaScience Inc volatility and volume are increasing
26 0 1
OVAS, W Long
OvaScience Inc volatility and volume are increasing

With increased volume and bullish engulfing pattern which finished double bottom formation, OVAS is an excellent pick to buy this week. Last week global fertility company reported ($0.62) EPS for the quarter, topping analysts’ consensus estimates of ($0.78) by $0.16. The business earned $0.19 million during the quarter, compared to analysts’ expectations of $0.21 ...

123 Show More Ideas
Ideas Scripts Chart
United States
United Kingdom
Home Stock Screener Forex Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Account and Billing Sign Out